Your browser doesn't support javascript.
loading
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
Aysha, Al-Ani; Rentsch, Clarissa; Prentice, Ralley; Johnson, Doug; Bryant, Robert V; Ward, Mark G; Costello, Samuel P; Lewindon, Peter; Ghaly, Simon; Connor, Susan J; Begun, Jakob; Christensen, Britt.
Afiliação
  • Aysha AA; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Rentsch C; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Prentice R; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Johnson D; Victorian Infectious Diseases Unit, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Bryant RV; Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
  • Ward MG; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, Australia.
  • Costello SP; Department of Gastroenterology, Monash University, Melbourne, Victoria, Australia.
  • Lewindon P; Department of Gastroenterology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Ghaly S; Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
  • Connor SJ; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, Australia.
  • Begun J; Department of Gastroenterology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Christensen B; Department of Gastroenterology, St Vincent's Hospital, Sydney, New South Wales, Australia.
Intern Med J ; 50(7): 798-804, 2020 07.
Article em En | MEDLINE | ID: mdl-32656985
ABSTRACT
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Administração dos Cuidados ao Paciente / Doenças Inflamatórias Intestinais / Infecções por Coronavirus / Pandemias / Gastroenterologia / Fatores Imunológicos Tipo de estudo: Etiology_studies / Guideline Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Administração dos Cuidados ao Paciente / Doenças Inflamatórias Intestinais / Infecções por Coronavirus / Pandemias / Gastroenterologia / Fatores Imunológicos Tipo de estudo: Etiology_studies / Guideline Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2020 Tipo de documento: Article